
Clinical Trial Delays: Key Challenges from Phase I to III
Learn why over 85% of clinical trials face delays. This analysis covers the key scientific, operational, and regulatory challenges that slow drug progression.

Learn why over 85% of clinical trials face delays. This analysis covers the key scientific, operational, and regulatory challenges that slow drug progression.

Exploring how modern RTSM solutions are evolving to improve patient experience in clinical trials, featuring innovative approaches to recruitment, engagement, and trial management.